IGC Pharma (IGC) Change in Inventory (2010 - 2025)

IGC Pharma (IGC) posted quarterly Change in Inventory of -$6000.0 for Q3 2025, up 45.45% quarter-over-quarter from -$11000.0 in Q2 2025.

IGC Pharma (IGC) Change in Inventory (2010 - 2025) Analysis & Trends

IGC Pharma (IGC) has reported Change in Inventory for 16 consecutive years, with -$6000.0 the latest figure, recorded in Q3 2025.

In Q3 2025, Change in Inventory changed N/A year-over-year to -$6000.0; the TTM figure through Sep 2025 stood at -$167000.0 (up 83.68% YoY), while the FY2025 annual figure was -$180000.0, up 82.14% from the prior year.
Change in Inventory improved to -$6000.0 in Q3 2025 per IGC's latest filing, from -$11000.0 in the prior quarter.
Across five years, Change in Inventory topped out at $322000.0 in Q1 2021 and bottomed at -$1.9 million in Q1 2022.
Historically, Change in Inventory has averaged -$206111.1 across 5 years, with a median of -$8000.0 in 2023.
On a YoY basis, Change in Inventory climbed as much as 3800.0% in 2022 and fell as far as 683.54% in 2022.
IGC Pharma's Change in Inventory stood at -$71000.0 in 2021, then surged by 97.18% to -$2000.0 in 2022, then jumped by 1250.0% to $23000.0 in 2023, then slumped by 434.78% to -$77000.0 in 2024, then jumped by 92.21% to -$6000.0 in 2025.
Business Quant data shows IGC's Change in Inventory at -$6000.0 in Q3 2025, -$11000.0 in Q2 2025, and -$73000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Vertex Pharmaceuticals	139.78 Bn	131.93 Bn	2.84 Bn	27.70 Mn
2	Regeneron Pharmaceuticals	86.58 Bn	78.59 Bn	3.93 Bn	28.20 Mn
3	Argenx Se	65.29 Bn	60.11 Bn	1.37 Bn	-
4	Moderna	58.86 Bn	53.73 Bn	52.00 Mn	132.00 Mn
5	BeOne Medicines	42.12 Bn	37.02 Bn	1.53 Bn	47.15 Mn
6	Alnylam Pharmaceuticals	31.73 Bn	28.42 Bn	992.69 Mn	-280,000.00
7	BioNTech SE	28.19 Bn	9.80 Bn	668.28 Mn	135.26 Mn
8	Insmed	27.53 Bn	26.37 Bn	358.27 Mn	12.97 Mn
9	Royalty Pharma	27.24 Bn	26.41 Bn	-	-
10	IGC Pharma	28.20 Mn	27.94 Mn	-	-

Download Data